Thinking outside the box

Tetsu Maruyama, PhD, Chief Scientific Officer of the Dementia Discovery Fund (DDF) offers some words of encouragement to his colleagues in the field, suggesting the optimal approaches to creating new drugs against dementia and explaining what an integrated solution to Alzheimer’s disease entails. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.

Share this video